Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension
Frontiers in Pharmacology · 15.06.2023 · 14
DOI: 10.3389/fphar.2023.1209890 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.06.2023. Verfasst von Xiaolin Liao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hypertension generally causes target organ damage (TOD) in the heart, brain, kidney, and blood vessels. This can result in atherosclerosis, plaque formation, cardiovascular and cerebrovascular events, and renal failure. Recent studies have indicated that mitochondrial dysfunction is crucial in hypertensive target organ damage. Consequently, mitochondria-targeted therapies attract increasing attention. Natural compounds are valuable resources for drug discovery and development. Many studies have demonstrated that natural compounds can ameliorate mitochondrial dysfunction in hypertensive target organ damage. This review examines the contribution of mitochondrial dysfunction to the development of target organ damage in hypertension. Moreover, it summarizes therapeutic strategies based on natural compounds that target mitochondrial dysfunction, which may be beneficial for preventing and treating hypertensive target organ damage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
- Scientific Research Department, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liao, X., Han, Y., He, Y., Liu, J., & Wang, Y. (2023). Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1209890
Vancouver
Liao X, Han Y, He Y, Liu J, Wang Y. Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1209890
BibTeX
@article{Liao2023,
author = {Liao, Xiaolin and Han, Yuanshan and He, Ying and Liu, Jianjun and Wang, Yuhong},
title = {Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1209890}
}
EUVIMED